Skip to contentB
BIO-TECHNE Corp
B
TECHBIO-TECHNE Corp Q4 2014 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$92.52M$92.52Mderived+16.4% vs Q4 2013 Net Income$26.82M$26.82Mderived−5.6% vs Q4 2013 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BIO-TECHNE Corp · CIK 842023 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$63,593,000+7.6% Operating Incomederived$38,846,000N/M Operating Cash Flowderived$37,921,000+26.5% Free Cash Flowderived$35,819,000+45.4% Margins · derivedGross margin68.7%−5.7 pt vs Q4 2013
Operating margin42.0%+191.1 pt vs Q4 2013
Net margin29.0%−6.8 pt vs Q4 2013
ended Jun 30, 2014 · filed Aug 29, 2014 · 60 d after period end